Stock Comparison · Live Data
ABBV vs BMY
Side-by-side comparison of ABBVIE INC. (ABBV), Bristol-Myers Squibb Co. (BMY) — live price, market cap, day change, and sector classification.
ABBV vs BMY — which stock is the better buy?
ABBVIE INC. (ABBV) leads this comparison by market capitalization at $365.43B. ABBV is today's top mover with a +0.21% move, while BMY sees the highest trading volume at 4.88M shares.
Whether ABBV vs BMY is the better investment for your portfolio depends on your time horizon, risk tolerance, and existing exposure. ArbibX runs Claude AI across thousands of US stocks daily and surfaces the most actionable picks with confidence scores and target prices. For a personalized analysis on ABBV vs BMY, use the in-app "Ask Claude" assistant — it sees the live prices from this page plus your portfolio context.
Per-stock breakdown
- ABBV — ABBVIE INC. trades at $207.03, day change +0.21%, pharmaceutical preparations sector, market cap $365.43B.
- BMY — Bristol-Myers Squibb Co. trades at $57.30, day change -1.58%, pharmaceutical preparations sector, market cap $118.87B.
Frequently asked
Which is the better stock — ABBV vs BMY?
It depends on your goals. ABBVIE INC. (ABBV) has the larger market cap at $365.43B. Today ABBV is the strongest performer (+0.21%). For a qualitative read on each name use the AI Top 15 tab on ArbibX.
What is the current price of ABBV and BMY?
ABBV is trading at $207.03 (+0.21% on the day). BMY is trading at $57.30 (-1.58% on the day). Live prices update every minute on the ArbibX terminal.
How does ArbibX compare stocks?
ArbibX pulls live snapshot data from Polygon.io and pairs it with Claude-powered AI analysis. Comparison pages show price, market cap, day change, sector, and key technicals side by side. The deeper analysis (target prices, signals, risk notes) lives on each ticker's dedicated page.
Not financial advice · For informational purposes only · Data via Polygon.io